About 2.7 million people in the U.S. live with inflammatory bowel diseases, which cause long-term inflammation in the ...

A new Crohn’s treatment that involves guselkumab showed outstandingly greater rates of endoscopic improvement, which are vital for reducing long-term complications.

Stelara was approved in 2016 to treat Crohn’s disease and in 2019 for ulcerative colitis. It was the first biologic medicine that targets interleukin (IL)-12 and IL-23.

A new study led by researchers at Mount Sinai Health System has identified distinct biological signatures in patients with ...

IBD flare-ups can affect your daily life. Ways to manage these flare-ups may include stress management, dietary changes, ...

A low-emulsifier-containing diet led to a threefold increased likelihood of improvement in symptoms of Crohn’s disease ...

If you love your morning cup of coffee but aren’t sure if it’s helping or hurting your Crohn’s symptoms, here’s what to know.

Women with IBD may experience additional symptoms such as irregular or heavier periods, joint pain, pain during sex, and ...

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

IgG-seq identifies enteric bacteria recognized by serum IgG. Credit: Gut Microbes (2025). DOI: 10.1080/19490976.2025.2464221 ...

The research was conducted by the Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES 21) consortium, a group of international IBD and public health experts led by Gilaad G.